Evercore ISI Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $27.00

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) had its price objective lowered by equities research analysts at Evercore ISI from $28.00 to $27.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has an “outperform” rating on the medical instruments supplier’s stock. Evercore ISI’s price target indicates a potential upside of 10.61% from the stock’s current price.

A number of other equities research analysts also recently weighed in on XRAY. Robert W. Baird decreased their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. Needham & Company LLC lowered their price target on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research report on Friday, May 3rd. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of DENTSPLY SIRONA in a report on Monday. Finally, Piper Sandler reissued a “neutral” rating and set a $32.00 price target (down from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $34.33.

View Our Latest Stock Analysis on DENTSPLY SIRONA


Shares of XRAY stock opened at $24.41 on Tuesday. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 12 month low of $23.94 and a 12 month high of $41.65. The stock has a 50 day moving average of $26.77 and a 200-day moving average of $31.17. The firm has a market cap of $5.07 billion, a PE ratio of -55.48, a price-to-earnings-growth ratio of 1.10 and a beta of 1.01.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same quarter last year, the firm earned $0.39 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 2.6% compared to the same quarter last year. On average, equities analysts predict that DENTSPLY SIRONA will post 2.02 EPS for the current year.

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 3,577 shares of the stock in a transaction dated Friday, May 31st. The stock was bought at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the transaction, the director now directly owns 58,374 shares in the company, valued at $1,631,553.30. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.52% of the company’s stock.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors have recently made changes to their positions in the stock. Norges Bank acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at about $114,207,000. Nuance Investments LLC grew its stake in DENTSPLY SIRONA by 30.4% in the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after acquiring an additional 2,702,457 shares during the period. Generation Investment Management LLP increased its stake in DENTSPLY SIRONA by 43.4% during the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock worth $234,830,000 after purchasing an additional 1,998,012 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of DENTSPLY SIRONA by 21.1% during the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock worth $289,640,000 after acquiring an additional 1,419,503 shares during the period. Finally, SG Americas Securities LLC lifted its position in DENTSPLY SIRONA by 2,959.1% in the 1st quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock valued at $45,584,000 after acquiring an additional 1,328,525 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.


(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.